First-in-Human PET studies with CTT1057, a novel fluorine-18 labeled agent targeting PSMA in prostate cancer

被引：0
|
作者：
Behr, Spencer [2 ]
Aggarwal, Rahul [2 ]
Seo, Youngho [2 ]
Gao, Kenneth [2 ]
Ravanfar, Vahid [2 ]
Slater, James [2 ]
Jivan, Salma [2 ]
Blecha, Joseph [2 ]
Langton-Webster, Beatrice [1 ]
Berkman, Clifford [3 ]
VanBrocklin, Henry [2 ]
机构：
[1] Canc Targeted Technol, Woodinville, WA USA
[2] Univ Calif San Francisco, San Francisco, CA 94143 USA
[3] Washington State Univ, Chem, Pullman, WA 99164 USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2017年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1073
引用
收藏
页数：2
相关论文
共 50 条
  • [41] First-in-human PET/CT imaging with 152Tb-DOTATOC in neuroendocrine neoplasm and of prostate cancer using 152Tb-PSMA-617
    Singh, A.
    Baum, R. P.
    Mueller, D.
    Senftleben, S.
    Benesova, M.
    Vermeulen, C.
    Gnesin, S.
    Koster, U.
    Johnston, K.
    Kulkarni, H. R.
    Turler, A.
    Schibli, R.
    Prior, J. O.
    van der Meulen, N. P.
    Mueller, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S293 - S294
  • [42] Biodistribution and radiation dosimetry of the novel 18F-labeled prostate-specific membrane antigen-ligand PSMA-7 for PET/CT in prostate cancer patients
    Hohberg, Melanie
    Dietlein, Markus
    Kobe, Carsten
    Dietlein, Felix
    Zlatopolskiy, Boris
    Krapf, Philipp
    Wild, Markus
    Taeger, Philipp
    Neumaier, Bernd
    Drzezga, Alexander
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [43] Biodistribution and radiation dosimetry of the novel 18F-labeled prostate-specific membrane antigen-ligand PSMA-7 for PET/CT in prostate cancer patients
    Hohberg, M.
    Dietlein, M.
    Kobe, C.
    Dietlein, F.
    Zlatopolskiy, B.
    Krapf, P.
    Wild, M.
    Taeger, P.
    Neumaier, B.
    Drzezga, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S149 - S150
  • [44] CD13 as a potential membrane marker in PSMA-negative prostate cancer and first-in-human study of [18F]AlF-CD13-L1 PET/CT imaging
    Tang, W.
    Zhou, M.
    Lu, C.
    Qi, L.
    Zhang, Y.
    Tang, Y.
    Gao, X.
    Hu, S.
    Cai, Y.
    ANNALS OF ONCOLOGY, 2024, 35
  • [45] Intraindividual Comparison of novel 18F-PSMA1007 and Al18F-PSMA-HBED-CC PET/CT in the Prospective Evaluation of Prostate Cancer Patients with Biochemical Relapse: First experience in Uruguay
    dos Santos, Gerardo
    Monica, Rodriguez
    Javier, Giglio
    Eduardo, Savio
    Alonso, Omar
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62
  • [46] Phase I, First-in-Human Study of BMS747158, a Novel 18F-Labeled Tracer for Myocardial Perfusion PET: Dosimetry, Biodistribution, Safety, and Imaging Characteristics After a Single Injection at Rest
    Maddahi, Jamshid
    Czernin, Johannes
    Lazewatsky, Joel
    Huang, Sung-Cheng
    Dahlbom, Magnus
    Schelbert, Heinrich
    Sparks, Richard
    Ehlgen, Alexander
    Crane, Paul
    Zhu, Qi
    Devine, Marybeth
    Phelps, Michael
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52 (09) : 1490 - 1498
  • [47] Phase I, first-in-human study of XTR004, a novel 18F-labeled tracer for myocardial perfusion PET: Biodistribution, radiation dosimetry, pharmacokinetics, and safety after a single injection at rest
    Ren, Chao
    Pan, Qingqing
    Fu, Chao
    Wang, Peipei
    Zheng, Zhiquan
    Hsu, Bailing
    Huo, Li
    JOURNAL OF NUCLEAR CARDIOLOGY, 2024, 34
  • [48] CD13 as a potential theranostic target for prostate-specific membrane antigen-negative prostate cancer and first-in-human study of [18F]AlF-CD13-L1 PET/CT imaging
    Tang, Wei
    Zhou, Ming
    Lu, Chenxi
    Qi, Lin
    Zhang, Ye
    Tang, Yongxiang
    Gao, Xiaomei
    Hu, Shuo
    Cai, Yi
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2025,
  • [49] First-in-human phase I study of HPN424, a tri-specific half-life extended PSMA-targeting T-cell engager in patients with metastatic castration-resistant prostate cancer (mCRPC).
    Bendell, Johanna C.
    Fong, Lawrence
    Stein, Mark N.
    Beer, Tomasz M.
    Ross, Ashley
    Gao, Xin
    Weitzman, Aaron
    Austin, Richard
    Ganti, Vaishnavi
    Law, Che-Leung
    Lemon, Bryan
    Wesche, Holger
    De Bono, Johann S.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [50] Comparison of novel PSMA-targeting [177Lu]Lu-P17-087 with its albumin binding derivative [177Lu]Lu-P17-088 in metastatic castration-resistant prostate cancer patients: a first-in-human study
    Li, Linlin
    Wang, Jiarou
    Wang, Guochang
    Wang, Rongxi
    Jin, Wenbin
    Zang, Jie
    Sui, Huimin
    Jia, Chenhao
    Jiang, Yuanyuan
    Hong, Haiyan
    Zhu, Lin
    Alexoff, David
    Ploessl, Karl
    Kung, Hank F.
    Zhu, Zhaohui
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 (09) : 2794 - 2805
12345